The allergy diagnostics and therapeutics market was valued at USD 34.64 billion in 2024 and is estimated at USD 37.52 billion in 2025. Polaris Market Research projects it to reach USD 78.51 billion by 2034, exhibiting a CAGR of 8.5% during the forecast period 2025–2034. Growth is supported by the rising prevalence of allergic conditions and advances in allergy immunotherapy. Key players...